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Heart failure (HF) is associated with progressive ventricular remodeling and impaired contraction 
that affects distinctly various regions of the myocardium. Our study applied cardiac magnetic 
resonance (CMR) feature tracking (FT) to assess comparatively myocardial strain at 3 distinct 
levels: subendocardial (Endo-), mid (Myo-) and subepicardial (Epi-) myocardium across an 
extended spectrum of patients with HF. 59 patients with HF, divided into 3 subgroups as 
follows: preserved ejection fraction (HFpEF, N = 18), HF with mid-range ejection fraction 
(HFmrEF, N = 21), HF with reduced ejection fraction (HFrEF, N = 20) and a group of age- gender- 
matched volunteers (N = 17) were included. Using CMR FT we assessed systolic longitudinal 
and circumferential strain and strain-rate at Endo-, Myo- and Epi- levels. Strain values were the 
highest in the Endo- layer and progressively lower in the Myo- and Epi- layers respectively, this 
gradient was present in all the patients groups analyzed but decreased progressively in HFmrEF 
and further on in HFrEF groups. GLS decreased with the severity of the disease in all 3 layers: 
Normal > HFpEF > HFmrEF > HFrEF (Endo-: −23.0 ± 3.5 > −20.0 ± 3.3 > −16.4 ± 2.2 > −11.0 ± 3.2, 
p < 0.001, Myo-: −20.7 ± 2.4 > −17.5.0 ± 2.6 > −14.5 ± 2.1 > −9.6 ± 2.7, p < 0.001; Epi-: 
−15.7 ± 1.9 > −12.2 ± 2.1 > −10.6 ± 2.3 > −7.7 ± 2.3, p < 0.001). In contrast, GCS was not 
different between the Normal and HFpEF (Endo-: −34.5 ± 6.2 vs −33.9 ± 5.7, p = 0.51; Myo-: 
−21.9 ± 3.8 vs −21.3 ± 2.2, p = 0.39, Epi-: −11.4 ± 2.0 vs −10.9 ± 2.3, p = 0.54) but was, as 
well, markedly lower in the systolic heart failure groups: Normal > HFmrEF > HFrEF (Endo-: 
−34.5 ± 6.2 > −20.0 ± 4.2 > 12.3 ± 4.2, p < 0.001; Myo-: −21.9 ± 3.8 > −13.0 ± 3.4 > −8.0 ± 2.7. 
p < 0.001; Epi-: −11.4 ± 2.0 > −7.9 ± 2.3 > −4.5 ± 1.9. p < 0.001). CMR feature tracking multilayer 
strain assessment identifies large range differences between distinct myocardial regions. Our data 
emphasizes the importance of sub-endocardial myocardium for cardiac contraction and thus, its 
predilect role in imaging detection of functional impairment. CMR feature tracking offers a convenient, 
readily available, platform to evaluate myocardial contraction with excellent spatial resolution, 
rendering further details about discrete areas of the myocardium. Using this technique across distinct 
groups of patients with heart failure (HF), we demonstrate that subendocardial regions of the 
myocardium exhibit much higher strain values than mid-myocardium or subepicardial and are more 
sensitive to detect contractile impairment. We also show comparatively higher values of circumferential 
strain compared with longitudinal and a higher sensitivity to detect contractile impairment. A newly 
characterized group of patients, HF with mid-range ejection fraction (EF), shows similar traits of 
decompensation but has relatively higher strain values as patients with HF with reduced EF.
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Heart failure represents worldwide a massive burden and, despite progresses in treatment strategies including 
medication and cardiac device therapy1, due to general aging, the absolute number of cases increased with 12% in 
the last decade2, with an anticipated prevalence increase of 46% before 20303. An increased preponderance and 
higher mortality of patients with diastolic heart failure3 warrants improvements towards a more particularized 
therapeutic approach and follow-up.
Human heart anatomy is complex, comprising 3 distinct layers of muscular fibers with different angular ori-
entation, starting from a longitudinal distribution toward the endocardium and progressively being interspersed 
by oblique fascicles with contrary helical orientation from base to the apex and, respectively, by circular fasci-
cles towards the epicardium. This particular architecture is essential to ensure a specific pattern of motility and 
force generation during the cardiac cycle: descend of the mitral valve plane towards the apex, uniform decrease/
increase in short-axis diameter, base to apex twisting/untwisting4,5. Complexity to the assessment of heart con-
traction increases when myocardium undergoes pathologic hypertrophic remodeling or develops microvascu-
lar dysfunction due to various systemic syndromes such as hypertension, obesity, diabetes or coronary artery 
disease6.
Being less influenced by haemodynamic forces and tethering effect of adjacent segments, strain rate imaging 
holds the promise to render an adequate evaluation of the spatial contractility parameters (longitudinal, circum-
ferential and radial strain) measurable at each voxel level over the cardiac cycle7. Longitudinal strain is a powerful 
predictor of mortality in patients with acute8 and chronic heart failure9, overpassing widely used parameters such 
as ejection fraction (EF) or left ventricular (LV) volumes. Moreover, in patients with myocardial infarction (MI), 
reduced myocardial strain values are quantitatively correlated with the extent of MI and respectively, with the 
incidence of adverse event and prognostic10.
CMR feature tracking (FT) technique provides information about myocardial mechanics. Myocardial strain 
and strain rate are obtained from the analysis of conventional balanced steady state free precession (bSSFP) cine 
images11, with an excellent inter- observer, intra- observer agreement and high inter- study reproducibility12,13.
The purpose of this study was to assess the longitudinal and circumferential strain at the level of 3 distinct 
myocardial layers (subendocardial, myocardial and subepicardial) in HF patients and correspondent age- and 
gender- matched normal subjects and give an account of the variability of dimension range and discriminating 
diagnostic ability of these parameters.
Methods
Study population. The study was approved by the Ethics Committee of the Charité-University-Medicine in 
Berlin, complied with the Declaration of Helsinki and was registered at the German Register for Clinical Studies 
(DRKS) (registration number: DRKS00015615). All individuals were fully informed about the aim, rationale 
and detailed protocol of the study (subject information leaflet) and consequently written informed consent was 
obtained before participation. For this study, we included prospectively, patients with a diagnosis of HF who 
were subdivided according to recent guidelines14 into 3 groups, as follows: (1) patients with HF with preserved 
ejection fraction (HFpEF), where EF ≥50% but diastolic dysfunction is present (an E/e′ ≥13 and a mean e’ septal 
and lateral wall <9 cm/s) and plasma levels of NT-proBNP >125 pg/mL, (2) patients with HF with mid-range 
ejection fraction (HFmrEF), where EF = 40–49% and similar additional criteria are present, (3) patients with HF 
with reduced ejection fraction (HFrEF) where EF < 40%. Exclusion criteria were: more than trivial MR, uncon-
trolled hypertension, atrial fibrillation, incompleteness, reduced quality or presence of artifacts in the images 
acquired. Inclusion of patients took into account a match for age and gender distribution between the groups. For 
comparison a fourth, similar group of age- and gender- matched volunteers have been recruited, and underwent 
an identical protocol with the HF subjects. The final numbers of subjects included, demographics and descriptive 
statistics of the parameters took into consideration are shown in Table 1.
Cardiac magnetic resonance. All CMR images were acquired using a 1.5 T (Achieva, Philips Healthcare, 
Best, The Netherlands) MRI scanners with a 5-channel cardiac surface coil in a supine position. All study partic-
ipants were scanned using identical comprehensive imaging protocol. The study protocol included initial scouts 
to determine cardiac imaging planes. Cine images were acquired using ECG-gated bSSFP sequence with multi-
ple breath-holds at end-expiration in three left ventricular (LV) long-axis (two-chamber (2Ch), three-chamber 
(3Ch) and four-chamber (4Ch)) planes. The ventricular two-chamber and four-chamber planes were used to 
plan a stack of short-axis slices covering the entire LV. The following imaging parameters were used: for 1.5 T 
scanner: repetition time (TR) = 3.3 ms, echo time (TE) = 1.6 ms, flip angle = 60°, voxel size = 1.8 × 1.7 × 8.0 mm3 
and 50 phases per cardiac cycle in accordance with standards of procedure established in our unit and described 
previously15.
Image analysis. All images were analyzed offline using commercially available software (Medis Suite, version 
3.1, Leiden, The Netherlands) in accordance to recent consensus document for quantification of LV function 
using CMR16. Strain analysis included 2Ch, 3Ch and 4Ch cine images, and respectively, 3 preselected slices from 
the LV short-axis stack to correspond to basal, mid-ventricular and apical levels. The endocardial and epicar-
dial contours drawn on cine images with QMass version 8.1 were transferred to QStrain RE version 2.0, where, 
after the application of tissue tracking algorithm, endocardial and epicardial borders were detected throughout 
all the cardiac cycle. These long-axis cine images were further used to compute global myocardial longitudinal 
(GLS) (Fig. 1A) and, respectively, short-axis images were used to compute global circumferential (GCS) (Fig. 1B) 
strain and strain-rate at 3 distinct levels within the myocardial volume: Endo- subendocardial myocardium, 
Myo- mid-myocardium, and Epi- subepicardial myocardium. The global values for each layer were respectively 
obtained through averaging the values according to an American Heart Association (AHA) 17 segments model17, 
apex being excluded, as follows: GCS from averaging CS for 6 basal, 6 mid and 4 apical segmental individual 
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values; GLS from 2Ch, 3Ch and 4Ch averaging 6 basal, 6 mid and 4 apical segments using a bull-eye view algo-
rithm. For ROC analyses, individual values of peak strain corresponding to each 17 AHA segment, apex excluded, 
was rendered by the Medis platform and these values were individually considered and included in the statistical 
analysis. We assessed also the global values of radial strain in all subjects included in the study (data presented in 
the Supplemental Material), however our findings, in agreement with previous studies18, show a lower reproduc-
ibility and less sensitivity to detect differences in myocardial deformation between groups, suggesting further its 
reduced potential role in clinical practice.
LV Volumetry and mass were derived from segmentation of endocardial and epicardail contours in 
end-diastole and end-systole phases respectively, following the current guidelines recommendations19. Atrial 
surfaces were derived from the CMR cine sequences corresponding to the maximal expansion of the atrial cham-
bers following the current guidelines20. For quantitative analysis all the volumes, areas and mass were indexed 
with BSA.
Statistical analysis. Statistical analysis was carried out with SPSS IBM statistics, version 25. Normality of 
variables was assessed by visual assessment of normality curves and the Shapiro-Wilk test. Intra-subject compar-
ison between strain values at 3 different levels Endo-, Myo-, Epi- were performed using 1-way repeated measures 
Controls HFpEF HFmrEF HFrEF P Value
Patients in group, n 17 18 21 20
Age, y 63.9 ± 6.9 71.5 ± 7.1 68.3 ± 9.4 64.7 ± 9.2 0.12
Male subjects 9 9 13 12 0.75
Heart rate (bpm) 60.2 ± 9.4 63.5 ± 9.1 65.8 ± 8.5 66.1 ± 10.0 0.23
LVEDV (ml) 126 ± 31 120 ± 31 173 ± 32 244 ± 73 <0.001§
LVEDVi (ml/m2) 64 ± 11 62 ± 14 90 ± 15 116 ± 31 <0.001§
LVESV (ml) 45 ± 16 48 ± 17 96 ± 20 164 ± 51 <0.001§
LVESVi (ml/m2) 25 ± 2 27 ± 9 53 ± 11 91 ± 28 <0.001§
LV Stroke Volume (ml) 81 ± 16 72 ± 18 77 ± 14 80 ± 26 0.87
LA Surface (cm2) 20.4 ± 4.1 21.1 ± 6.0 23.1 ± 6.8 27.7 ± 6.1 0.003§
RA Surface (cm2) 22.4 ± 5.2 21.6 ± 6.0 20.1 ± 4.5 21.6 ± 4.8 0.65
LVEF (%) 64.4 ± 5.2 60.0 ± 7.2 44.2 ± 3.0 32.3 ± 6.0 <0.001§
LV-EDD(mm) 49.1 ± 4.4 50.7 ± 4.3 57.4 ± 5.9 65.4 ± 7.5 <0.001§
Septum(mm) 9.2 ± 1.7 11.2 ± 2.2 11.7 ± 1.7 11.8 ± 3.0 <0.001§
Lateral Wall(mm) 7.2 ± 1.0 7.4 ± 1.5 7.1 ± 1.7 8.1 ± 2.2 0.35
LVM (g) 93 ± 24 83 ± 23 112 ± 38 143 ± 40 <0.001§
LVMi (g/m2) 47.4 ± 9.2 43.4 ± 8.9 104.0 ± 48.3 131.2 ± 50.5 <0.001§
E/e′ ratio 10.9 ± 3.9 11.1 ± 4.3 11.1 ± 1.6 14.8 ± 6.2 0.09
NT-proBNP (ng/l) 94 ± 62 451 ± 512 885 ± 1146 2198 ± 3479 0.007§
Laboratory Values
Hemoglobin (g/dl) 13.9 ± 1.1 13.0 ± 1.3 13.7 ± 1.1 15.0 ± 1.1
Hematocrit 0.40 ± 0.03 0.38 ± 0.03 0.40 ± 0.03 0.44 ± 0.04
Creatinin (mg/dl) 0.87 ± 0.20 0.92 ± 0.18 1.06 ± 0.33 1.10 ± 0.39
GFR (ml/min) 81 ± 10 71 ± 15 71 ± 18 71 ± 21
Troponin T (ng/l) 7 ± 3 20 ± 17 19 ± 20 19 ± 12
CRP (mg/dl) 1.3 ± 1.4 2.9 ± 2.5 2.9 ± 4.1 1.0 ± 0.7
WBC (n/nl) 6.1 ± 1.6 7.1 ± 2.3 8.4 ± 2.3 8.5 ± 2.4
Comorbidities, risk factors
CAD 0 12 14 11 <0.001§
Peripheric Artery Disease 0 5 3 2 0.11
Hypertension 6 12 15 12 0.12
Diabetes 2 4 5 3 0.72
Hypercholesterolemia 4 12 14 11 0.031§
COPD 0 1 3 1 0.34
Smokers 6 7 8 6 0.94
Table 1. Daemographics. Basic Measurements. Comorbidities. LVEDV – left ventricle end diastolic volume, 
LVEDVi – left ventricle end diastolic volume index, LVESV – left ventricle end systolic volume, LVEF – LV 
ejection fraction, LV-EDD – left ventricle end diastole diameter, LA – left atrium, RA – right atrium, LVM – left 
ventricle mass, LVMi – left ventricle mass index, CAD – coronary artery disease, COPD – Chronic obstructive 
pulmonary disease. Values are given as mean ± SD unless stated otherwise. Comparison between groups are 
assessed through an ANOVA 1-way. P values were adjusted with the Bonferroni method, a level above 0.05 is 
considered significant. §Significant.
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ANOVA and respectively Tukey’s multiple comparison tests. Comparison between groups for continuous variables 
was performed with a 2-sided, independent-samples Student’s t test or 1-way ANOVA for normally distributed data 
and Mann-Whitney and Kruskal-Wallis tests for skewed data. When a significant p value was obtained using 1-way 
ANOVA, the group means were examined by unpaired t tests for normally distributed variables or log-transformed 
values (if non-normally distributed), followed by Bonferroni post-hoc correction. ROC analysis with determina-
tion of specific area under curve (AUC) and threshold Youden’s index to establish optimal predictive power were 
computed. Results are presented as mean ± SD. Values of p < 0.05 were considered statistically significant.
Results
Baseline characteristics. A total number of 140 patients with a diagnosis of HF were screened for the inclu-
sion criteria, as stated above, and a resultant number of 59 patients were finally recruited for the study, as follows: 
18 were diagnosed with HFpEF, 21 with HFmrEF and 20 with HFrEF. Patients with AF, haemodynamically signif-
icant valvulopathies, uncontrolled hypertension, generic contraindications for CMR such as implantable devices, 
severe renal insufficiency, claustrophobia, were excluded. There were no differences between the control group 
and HFpEF for LV end-diastolic or end-systolic volumes or ejection fraction, as expected LV end-diastolic vol-
ume was progressively larger in patients with HFmrEF and HFrEF respectively. Patients with HFmrEF and HFrEF 
had a more dilated ventricle and left atrium. LV wall thickness was slightly larger in all 3 HF groups compared 
with normal measured at septum level there was no difference in the free wall, LV mass was higher in HFmrEF 
and HFrEF groups but there was no difference between HFpEF and Normal. Incidence of relevant comorbidities 
demonstrated a uniform distribution between the pathology groups (details are shown in Table 1).
Longitudinal strain. Comparison between the the 4 groups. We initially looked for intrasubject 
paired comparisons between Endo-, Myo- and Epi- layers of the myocardium. Both GLS and GLSR, decreased 
progressively with an Endo-Myo-Epi gradient, p < 0.001. (means and standard errors for the 4 pathology groups 
are presented in Table 2). We further looked at the gradient between interlayer gradient across the groups: 
Endo-Epi gradient decreased between Normal and HFrEF (ΔGLS = −7.3 ± 4.2 vs −3.2 ± 1.9, p < 0.001) and 
respectively between HFmrEF and HFrEF (ΔGLS = −5.8 ± 2.7 vs −3.2 ± 1.9, p = 0.045), but was not different 
between Normal and HFpEF (ΔGLS = −7.3 ± 4.2 vs −7.8 ± 3.3) (Fig. 2A).
Figure 1. Range Variability of Multilayer Myocardial Strain across Different Stages of Heart Failure. (A) CMR 
Feature Tracking Assessment of Multilayer Longitudinal Strain: multilayer Longitudinal Strain in representative 
subjects from the 4 pathology groups, from left to right: Normal, HFpEF, HFmrEF, HFrEF. For each case on the 
vertical, from up to down, are shown respectively:long- axis 4Ch Cine Image in end-diastole, Global 
Longitudinal Strain vs time curves at 3 distinct myocardial layers, underlined Endo-, Myo- and Epi- myocardial 
layers at which the strain values were assessed, long-axis 4Ch Cine Image in end-systole. (B) CMR Feature 
Tracking Assessment of Multilayer Circumferential Strain: multilayer Circumferential Strain in the same 
representative subjects from the 4 groups, from left to right: Normal, HFpEF, HFmrEF, HFrEF. For each case on 
the vertical, from up to down, are shown, respectively: short-axis Basal Cine Image in end-diastole, Global 
Circumferential Strain vs time curves at 3 distinct myocardial layers, underlined Endo-, Myo- and Epi- 
myocardial layers at which the strain values were assessed, short-axis Basal Cine Image in end-systole.  
(C) Global Longitudinal Srain and (D) Global Circumferential Strain across the 4 pathology groups: multilayer 
assessment of Endo-, Myo-, Epi- layers of left ventricular myocardium. Normal ( ) normal age-, gender- 
matched control, HFpEF ( ) patients with HF with preserved EF, HFmrEF ( ) patients with HF with mid-
range reduced EF, HFrEF ( ) patients with HF with reduced EF.
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We further compared the GLS values between the groups at every of the 3 multilayer levels between the 
4 pathology groups. (results are summarized in Tabel 2). GLS was able to discriminate between Normal and 
HFpEF groups (Endo-: −23.0 ± 3.5 vs −20.0 ± 3.3, p = 0.020; Myo-: −20.7 ± 2.4 vs −17.5.0 ± 2.6, p = 0.001; Epi-: 
−15.7 ± 1.9 vs −12.2 ± 2.1, p < 0.001) (Fig. 1C). In contrast, GLSR was not different at Endo- level, showed a 
trend of decrease at Myo- level and is significant at Epi- level (−0.84 ± 0.11 vs −0.71 ± 0.15, p = 0.008) between 
these 2 groups. GLS and GLSR at all three levels was significantly higher in Normal than in patients with HFmrEF 
and HFrEF and, respectively, higher in HFmrEF than in the HFrEF, indicating a progressive loss of long axis 
contraction force in systolic HF.
Circumferential strain. Comparison between the 4 groups. Similarly GCS and GCSR intrasubject 
paired comparisons between Endo-, Myo- and Epi- layers of the myocardium showed a progressive decrease 
(p < 0.001, means and standard errors for the 4 pathology groups are presented in Table 2). Endo-Epi gradi-
ent decreased significantly in patients with systolic HF from Normal to HFmrEF and, progressively more in 
HFrEF (ΔGCS = −23.1 ± 5.3 vs −12.1 ± 3.8 vs −7.7 ± 3.2, p < 0.001 between Normal and HFmrEF and between 
HFmrEF and HFrEF respectively, p = 0.033) (Fig. 2B). GCS and GCSR showed no difference in any layer between 
Normal and HFpEF, but in contrast, GCS and GCSR decreased significantly between Normal and HFmrEF and 
between HFmrEF and HFrEF groups (Fig. 1D).
Segmental analysis of GLS and GCS. Regional variability of strain values. To establish if there are 
significant differences in the GLS and GCS respectively between the base, mid-ventricular and apical segments, 
we used the segmental strain values for the 17 AHA model segments, apex excluded, per each individual subject 
to compare the cumulated values for the 6 basal, 6 mid-ventricular and 4 apical segments. A total number of 1292 
segments were included in our analysis. To obtain strain values that correspond to a sub-region of the ventricle 
the strain values of corresponding segments were averaged accordingly. Results are summarized in Table 3 and 
represented in Fig. 3). In the Endo- layer, GLS had similar values between apex, mid-ventricle and base but in 
the Myo- and Epi- layers was lower in the apical segments in all 4 groups (P < 0.001) (Fig. 3A–C). GCS varied 
in amplitude with highest values apically and lowest at mid-ventricular level in normal subjects in Endo- and 
Myo- layers (Endo-: apical: −38.0 ± 8.5, mid-ventricle: −31.4 ± 6.3, basal: −34.1 ± 5.7, Myo-: apical: −23.8 ± 4.8, 
mid-ventricle: −19.8 ± 4.1, basal: −22.0 ± 3.7, p < 0.001) but not in Epi- layer. A similar distribution pattern was 
Controls HFpEF HFmrEF HFrEF
#P Value
Controls vs 
HFpEF
#P Value
Controls vs 
HFmrEF
#P Value
HFpEF vs 
HFmrEF
#P Value
HFmrEF vs 
HFrEF
Global Longitudinal Strain
Endo- (%) −23.0 ± 3.5 −20.0 ± 3.3 −16.4 ± 2.2 −11.0 ± 3.2 0.020 <0.001 <0.001 <0.001
Myo- (%) −20.7 ± 2.4 −17.5.0 ± 2.6 −14.5 ± 2.1 −9.6 ± 2.7 0.001 <0.001 <0.001 <0.001
Epi- (%) −15.7 ± 1.9 −12.2 ± 2.1 −10.6 ± 2.3 −7.7 ± 2.3 <0.001 <0.001 0.044 <0.001
†P Value Repeated Measure 
ANOVA in Pathology Groups <0.001 <0.001 <0.001 <0.001
Global Circumferential Strain
Endo- (%) −34.5 ± 6.2 −33.9 ± 5.7 −20.0 ± 4.2 −12.3 ± 4.2 0.51 <0.001 <0.001 <0.001
Myo- (%) −21.9 ± 3.8 −21.3 ± 2.2 −13.0 ± 3.4 −8.0 ± 2.7 0.39 <0.001 <0.001 <0.001
Epi- (%) −11.4 ± 2.0 −10.9 ± 2.3 −7.9 ± 2.3 −4.5 ± 1.9 0.54 <0.001 <0.001 <<0.001
Global Longitudinal
Strain Rate
Endo- (%/s) −1.18 ± 0.19 −1.13 ± 0.30 −0.85 ± 0.16 −0.58 ± 0.13 0.52 <0.001 <0.001 <0.001
Myo- (%/s) −1.05 ± 0.14 −0.94 ± 0.20 −0.75 ± 0.13 −0.50 ± 0.11 0.089 <0.001 <0.001 <0.001
Epi- (%/s) −0.84 ± 0.11 −0.71 ± 0.15 −0.60 ± 0.10 −0.46 ± 0.17 0.008 <0.001 0.010 <0.001
†P Value Repeated Measure 
ANOVA in Pathology Groups <0.001 <0.001 <0.001 <0.001
Global Circumferential
Strain Rate
Endo- (%/s) −1.79 ± 0.41 −1.86 ± 0.54 −1.02 ± 0.27 −0.72 ± 0.20 0.68 <0.001 <0.001 <0.001
Myo- (%/s) −1.14 ± 0.20 −1.12 ± 0.19 −0.70 ± 0.16 −0.53 ± 0.16 0.76 <0.001 <0.001 0.002
Epi- (%/s) −0.70 ± 0.13 −0.69 ± 0.08 −0.51 ± 0.13 −0.40 ± 0.17 0.74 <0.001 <0.001 0.005
†P Value Repeated Measure 
ANOVA in Pathology Groups <0.001 <0.001 <0.001 <0.001
Table 2. Global Logitudinal and Circumferential Strain and Strain-Rate. Endo- sub-endocardial myocardium 
layer, Myo- mid-myocardial layer, Epi- sub-epicardial myocardium layer, Controls – normal control volunteers, 
HFpEF – heart failure with preserved ejection fraction, HFmrEF – heart failure with mid-range ejection 
fraction, HFrEF – heart failure with reduced ejection fraction. Comparison between pathology groups are 
assessed through an ANOVA 1-way. #P values characterize multiple mean comparisons between groups, 
adjusted with the Bonferroni method, †P values characterize repeated measures ANOVA for intrasubject 
comparisons. A P value level above 0.05 is considered significant.
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present in the other groups, with the lowest mean in the mid-ventricular segments but the difference between 
these groups did not reach significance (Fig. 3D–F).
Segmental analysis of GLS and GCS. ROC analyses. In order to establish the sensitivity and specificity 
of each parameter analyzed to detect contractile impairment associated with HF, we derived the multilayer values 
of GLS and GCS for each individual segment, We then pooled the HFmrEF and HFrEF segments as patients 
with systolic heart failure and overt systolic impairment and compared this larger pool with the segments from 
normal controls. Quantified at a segmental level Endo- GCS showed the best combined specificity and sensitiv-
ity to discriminate contractile impairment with an AUC of 0.89, p < 0.001 (Fig. 4), while the for the Myo- GCS, 
AUC = 0.83 and for the Epi- GCS AUC = 0.70. At a segmental level, GLS has a similar discriminating capacity 
Figure 2. Interlayer Strain Gradient. Representation of (A) Global Longitudinal Strain and (B) Global 
Circumferential Strain Interlayer gradient (Δ) between Endo-Epi, Endo-Myo and Myo-Epi respectively in 
4 groups: Normal – normal age-, gender- matched control, HFpEF – patients with HF with preserved EF, 
HFmrEF – patients with HF with mid-range reduced EF, HFrEF – patients with HF with reduced EF.
Controls HFpEF HFmrEF HFrEF
P Value
 Controls vs 
HFpEF
P Value
 Controls vs 
HFmrEF
P Value
 HFpEF vs 
HFmrEF
P Value
 HFmrEF vs 
HFrEF
Regional Longitudinal Strain - Basal Segments
Endo- (%) −24.7 ± 3.3 −20.5 ± 2.9 −18.4 ± 3.7 −14.3 ± 2.9 <0.001 <0.001 0.06 0.005
Myo- (%) −24.7 ± 3.5 −22.1 ± 2.6 −18.9 ± 3.5 −14.3 ± 3.1 0.029 <0.001 0.005 <0.001
Epi- (%) −23.4 ± 3.6 −21.8 ± 3.2 −18.1 ± 4.1 −14.4 ± 3.5 0.15 <0.001 0.01 0.004
Regional Longitudinal Strain - Mid Ventricle Segments
Endo- (%) −28.0 ± 4.0 −24.7 ± 2.4 −19.6 ± 3.6 −15.8 ± 3.1 0.006 <0.001 <0.001 0.001
Myo- (%) −27.7 ± 3.8 −24.3 ± 2.8 −20.2 ± 4.0 −15.8 ± 3.5 0.008 <0.001 <0.001 <0.001
Epi- (%) −26.6 ± 4.3 −22.8 ± 4.0 −19.9 ± 4.1 −15.7 ± 3.8 0.019 <0.001 0.024 0.003
Regional Longitudinal Strain - Apical Segments
Endo- (%) −25.0 ± 7.3 −23.3 ± 5.7 −19.5 ± 4.9 −13.3 ± 6.1 0.81 0.031 0.016 0.002
Myo- (%) −19.3 ± 5.1 −16.7 ± 3.6 −14.6 ± 4.6 −10.5 ± 4.3 0.17 0.009 0.18 0.006
Epi- (%) −14.1 ± 4.2 −11.2 ± 3.0 −10.5 ± 6.5 −8.4 ± 3.2 0.018 0.064 0.82 0.014
Regional Circumferential Strain - Basal Segments
Endo- (%) −35.3 ± 6.0 −35.3 ± 5.6 −22.1 ± 4.2 −14.7 ± 3.6 0.85 <0.001 <0.001 <0.001
Myo- (%) −23.6 ± 3.7 −23.0 ± 3.8 −15.9 ± 2.7 −10.1 ± 2.2 0.54 <0.001 <0.001 <0.001
Epi- (%) −15.6 ± 2.3 −14.2 ± 2.3 −12.1 ± 2.0 −9.2 ± 1.5 0.16 <0.001 0.006 <0.001
Regional Circumferential Strain - Mid Ventricle Segments
Endo- (%) −32.6 ± 6.0 −32.9 ± 6.8 −21.3 ± 4.8 −14.4 ± 4.1 0.88 <0.001 <0.001 <0.001
Myo- (%) −21.3 ± 3.9 −21.3 ± 3.2 −14.6 ± 2.7 −10.4 ± 3.3 0.73 <0.001 <0.001 <0.001
Epi- (%) −14.1 ± 2.2 −14.6 ± 3.9 −10.6 ± 2.1 −8.4 ± 2.7 0.73 <0.001 <0.001 0.003
Regional Circumferential Strain - Apical Segments
Endo- (%) −38.7 ± 8.3 −35.5 ± 9.1 −24.6 ± 7.7 −16.4 ± 7.3 0.32 <0.001 <0.001 0.001
Myo- (%) −24.8 ± 4.4 −23.6 ± 4.4 −17.2 ± 4.9 −11.0 ± 5.1 0.44 <0.001 <0.001 <0.001
Epi- (%) −14.6 ± 3.2 −16.1 ± 4.6 −12.6 ± 4.2 −8.3 ± 4.0 0.24 0.052 0.015 <0.001
Table 3. Regional Longitudinal and Circumferential Strain. Endo- sub-endocardial myocardium layer, Myo- 
mid-myocardial layer, Epi- sub-epicardial myocardium layer, Controls – normal control volunteers, HFpEF – 
heart failure with preserved ejection fraction, HFmrEF – heart failure with mid-range ejection fraction, HFrEF 
– heart failure with reduced ejection fraction. Comparison between pathology groups are assessed through an 
ANOVA 1-way. A P value level above 0.05 is considered significant.
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(Endo-GLS AUC = 0.74, Myo-GLS AUC = 0.74, Epi-GLS AUC = 0.69) (Table 4). A ROC curve analysis to iden-
tify patients with HFpEF from Normal, GLS Endo-, Myo- and Epi- showed low but statistically significant dis-
criminating capacity. (data presented in Table 5 and Supplemental Table and Figures).
Scatterplot. Complementary role of GCS and GLS. We further applied the threshold values of Endo- 
GLS and Endo GCS- resulted from the segmental ROC analysis to divide our cohort (Fig. 5) in 4 quadrants: 
subjects with Normal GCS and GLS values, subjects with abnormal GCS but normal GLS, subjects with abnormal 
GLS but normal GCS, subjects with abnormal GCS and abnormal GLS. The graph gives an indication of the excel-
lent sensitivity of both GCS and GLS values to discriminate between normal and patients with systolic impair-
ment, practically all the patients with HFmrEF and HFrEF having their GCS under the threshold values and all 
but one HFmrEF patient with lower GLS than the respective GLS threshold. Interestingly, the same Endo- GLS 
threshold applied to this specific subgroup, divides the HFpEF into 2 subgroups, suggesting that roughly a half of 
these patients have a degree of GLS impairment.
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Figure 3. Regional Values of GLS and GCS across the 3 groups of patients with HF and Normal. (A) Endo-, (B) 
Myo- and (C) Epi- multilayer assessment of regional longitudinal strain and respectively (D) Endo-, (F) Myo- 
and (E) Epi- multilayer assessment of regional circumferential strain of left ventricular myocardium at 3 distinct 
ventricular levels Apical, Mid-ventricular and Basal in 4 groups: Normal – normal age-, gender- matched 
control, HFpEF – patients with HF with preserved EF, HFmrEF – patients with HF with mid-range EF, HFrEF – 
patients with HF with reduced EF.
0 50 100
0
50
100
Circumferential Strain
to detect HF with LV impairment
100% - Specificity%
Epi CS
Myo CS
Endo CS
0 50 100
0
50
100
Longitudinal Strain
to detect HF with LV impairment
100% - Specificity%
Epi LS
Myo LS
Endo LS
A B
Figure 4. Comparative ROC Analysis for Multilayer GLS and GCS Parameters. ROC analysis to discriminate 
patients with HF with LV impairment from Normal Subjects of multilayer. (A) Longitudinal Strain, and (B) 
Circumferential Strain (Endo LS – sub-endocardial longitudinal strain, Myo LS – mid-myocardial longitudinal 
strain, Epi LS, sub-epicardial longitudinal strain, Endo CS – sub-endocardial circumferential strain, Myo CS – 
mid-myocardial circumferential strain, Epi CS, sub-epicardial circumferential strain).
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Discussion
In this study, we applied CMR-FT to assess myocardial deformation at 3 distinct layers of the myocardium in 
patients with HF.
Our study findings can be summarized as follows:
•	 There is a marked heterogeneity of strain and strain values measured at the levels of sub-endocardial, mid and 
subepicardial myocardium with a significant positive gradient between endocardium (highest values) and 
epicardium (lowest values).
•	 This gradient is blunted in patients with more severely impaired EF suggesting the primary and proportion-
ally more important loss of physiological contractile properties of the subendocardial myocardium.
•	 GCS is not different between HFpEF patients and normal controls in any of the myocardial layers and our 
data suggests that this parameter cannot be used to detect contractile impairment in these patients.
•	 GLS is on average significantly lower in HFpEF compared with Normal but this parameter is not specific 
and, in our cohort, almost half of the HFpEF patients had normal GLS. Corollary, our study proposes that a 
GLS threshold could be used to identifiy in the HFpEF group a subgroup of patients with putative significant 
underlying systolic impairment.
•	 Endo- GCS shows the best ability to diagnose patients with systolic HF and, in tandem with Endo- GLS, to 
identify with maximal sensitivity patients with systolic HF from our cohort.
Firstly, we report an important difference of magnitude for both GLS and GCS values depending of the level at 
which these parameters are assessed. In both cases, there is a significant endo-epi gradient with the highest values 
found towards the endocardium and the lowest towards the epicardium. Our findings support the hypothesis 
that subendocardial fibers play a privileged role in maintaining a physiological contractile power with a greater 
quantitative contribution, compared with fibers with myocardial and epicardial distribution. Proportionally, the 
strain values measured at an endocardial level dropped more with the severity of heart failure and myocardial 
remodeling. In keeping with this paradigm, we showed that measuring GCS at an endocardial level offers the 
best parameter to discriminate patients with systolic impairment, even if milder, such as HFmrEF group, from 
a normal population. These findings were in line with previous results of Altiok et al.21 who used comparatively 
speckle tracking and strain-encoded magnetic resonance imaging methodology to detect segmental hypokinesia.
Several echocardiography studies assessed myocardial strain using a multilayer approach in normal sub-
jects22–25, coronary artery disease26, aortic stenosis27, hypertrophic cardiomyopathy28,29. There is a consensus 
among these studies regarding the existence of a marked gradient between subendocardial and subepicardial 
regions of the myocardium in normal subjects which decreases proportionally with the contractile impairment: 
AUC Threshold
P Value for 
ROC Curve Sensitivity, % Specificity, %
Segmental Longitudinal Strain
Endo-, % 0.74 (0.71–0.78) −20.2 <0.0001 66 71
Myo-, % 0.74 (0.70–0.77) −19.2 <0.0001 68 68
Epi-, % 0.69 (0.66–0.73) −15.6 <0.0001 58 72
Segmental Circumferential Strain
Endo-, % 0.89 (0.87–0.91) −28.1 <0.0001 83 81
Myo-, % 0.83 (0.81–0.86) −16.5 <0.0001 70 83
Epi-, % 0.70 (0.67–0.74) −10.5 <0.0001 60 71
Global Longitudinal Strain
Endo-, % 0.98 (0.94–1) −19.4 <0.0001 98 88
Myo-, % 0.99 (0.99–1) −16.4 <0.0001 95 100
Epi-, % 0.99 (0.96–1) −13.0 <0.0001 95 100
Global Circumferential Strain
Endo-, % 0.99 (0.96–1) −27.1 <0.0001 100 88.2
Myo-, % 0.97 (0.94–1) −17.7 <0.0001 98 88
Epi-, % 0.93 (0.87–1) −9.3 <0.0001 90 88
Other Parameters
LVM index (g/m2) 0.91 (0.82–0.99) 62.0 <0.0001 89 95
LVEDV index (ml/m2) 0.88 (0.78–0.97) 91.8 <0.0001 78 100
LA Area Index (cm2/m2) 0.68 (0.54–0.83) 24.5 0.032 46 94
RA Area Index (cm2/m2) 0.57 (0.40–0.74) 0.392
Table 4. ROC Analysis. Segmental and Global Longitudinal and Circumferential Strain to Predict Contractility 
Impairment in Patients with Systolic Heart Failure. Endo- sub-endocardial myocardium layer, Myo- mid-
myocardial layer, Epi- sub-epicardial myocardium layer, AUC –area under curve, a P value level above 0.05 is 
considered significant, LVM – left ventricular mass, LVEDV – left ventricular end diastolic volume, LA- left 
atrium, RA – right atrium.
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in coronary artery disease (CAD) patients this gradient decreases with the severity of coronary obstruction26, in 
hypertension it is only mildly blunted compared with hypertrophic cardiomyopathy28.
The relative contribution of GCS and GLS to pump function of the heart, in normal and pathologic conditions, 
is controversial30,31. Histologically, circumferential fibers outnumber those with longitudinal and transversal ori-
entation, especially at the base of the ventricle, with a ratio of 10:132. Using a mathematical modeling of the LV, 
Stokke et al.33 argued that GCS is accountable for generating two times more contractile force than GLS and 
with a steeper positive correlation with the EF. Our data indicate higher absolute values of circumferential than 
longitudinal strain and a more severe decrease of GCS from normal towards patients with systolic heart failure 
(HFmrEF and HFrEF), pari passu with the decrease in EF.
Based on a segmental approach we propose generic threshold values for both GCS and GLS to identify patients 
with contractile impairment. We showed further excellent sensitivity of these combined values to identify patients 
with HF and, moreover, to scale the severity of disease, efficiently separating HFmrEF from HFrEF. While EF is a 
robust prognostic factor in a large number of patients with frank HF, with severely depressed cardiac contraction, 
its role per se in borderline subnormal and mid-range EF patients seems to be more controversial34. Recent ESC 
guidelines14 identifies HFmrEF as a potentially different pathologic entity from the more typical HFrEF group. 
HFmrEF class comprises patients with symptoms but not signs of HF, an intermediate degree of systolic dysfunc-
tion (EF between 40 and 50%) and with other traits of the disease present such as elevated natriuretic peptides, 
diastolic dysfunction, enlarged left atrium. Initial echocardiography studies in HFmrEF show mixed traits shared 
by both HFrEF and HFpEF such as the combination of LV dilatation with depressed contraction and respec-
tively, increased stiffness and elevated diastolic filling pressures. Describing only discrete differences and similar 
AUC Threshold
P Value for 
ROC Curve Sensitivity, % Specificity, %
Segmental Longitudinal Strain
Endo-, % 0.58 (0.54–0.63) −27.1 0.0005 67 47
Myo-, % 0.58 (0.53–0.62) −31.81 0.0013 89 24
Epi-, % 0.57 (0.52–0.62) −15.6 0.0037 41 72
Global Longitudinal Strain
Endo-, % 0.67 (0.49–0.84) −24.1 0.0824 90 41
Myo-, % 0.78 (0.63–0.93) −20.3 0.0038 90 59
Epi-, % 0.89 (0.78–0.99) −13.0 <0.0001 65 100
Other Parameters
LVM index (g/m2) 0.65 (0.46–0.85) 0.1502
LVEDV index (ml/m2) 0.59 (0.38–0.80) 0.3880
LA Area Index (cm2/m2) 0.72 (0.53–0.92) 21.50 0.0314 80 71
RA Area Index (cm2/m2) 0.54 (0.33–0.75) 0.7057
E/e′ 0.62(0.37–0.87) 0.360
Table 5. Segmental and Global Longitudinal Strain to Predict Contractility Impairment in Patients 
with HFpEF. Endo- sub-endocardial myocardium layer, Myo- mid-myocardial layer, Epi- sub-epicardial 
myocardium layer, AUC –area under curve, a P value level above 0.05 is considered significant, LVM – left 
ventricular mass, LVEDV – left ventricular end diastolic volume, LA- left atrium, RA – right atrium.
Figure 5. Distribution of HF Patients and Normal according to GLS and GCS Threshold Values. Scatterplot 
with Endo- Global Longitudinal Strain and Endo- Global Circumferential values. Reference lines represent 
the threshold values obtained through ROC analysis and Youden’s index calculation. The 4 groups represented 
are Normal – normal age-, gender- matched control, HFpEF – patients with HF with preserved EF, HFmrEF – 
patients with HF with mid-range reduced EF, HFrEF – patients with HF with reduced EF.
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patterns in strain values and interlayer gradients between HFmrEF and HFrEF, our study suggests that HFmrEF 
follows a similar pathophysiological pathway with HFrEF and likely represent a more incipient stage.
Overall, approximately one half of the total number of patients diagnosed with HF have preserved EF. Systolic 
contractility in patients with diastolic HF is insufficiently explored and understood35. Importantly, in our study, 
GCS in HFpEF group was not different from normal. In agreement with previous echocardiography studies36,37, 
we found that GLS is on average decreased in the HFpEF group compared with controls, however, due to a wider 
variation, its specificity to discriminate HFpEF patients from controls is low (Fig. 4). Our findings support the 
idea that an underlying systolic impairment in patients with primarily diastolic heart failure is inconstant and, 
where present, tends to affect only the long-axis systolic contraction.
Clinical perspectives. The discrepancy in magnitude of strain values between endocardium and epicardium 
warrants a very careful approach to the resulting data. Despite representing a powerful tool to assess regional and 
global cardiac function, the strain imaging advent into day-by-day usage has been restricted so far by a modest 
concordance between methodologies to measure, compute and report these values.
Contractility is consistently impaired in patients with HFmrEF paralleling the degree of ventricular dilata-
tion suggesting that drugs targeting the ventricular remodeling such as angiotensin converting enzyme inhib-
itors, Spironolactone or β-blockers maintain their beneficial effects in this group of patients still insufficiently 
characterized38.
Limitations. We acknowledge several limitations of this study: (1) even if representative for a specific disease 
class, the groups of patients were small and more comprehensive studies are warranted to validate our findings in 
a widespread HF population, (2) in most of our patients the etiology of heart failure is mostly related to coronary 
artery disease and previous acute coronary events, an extrapolation of our findings to a more complex group of 
HF patients, especially those affected by an intrinsic cardiomyopathy, is warranted, (3) myocardial deformation 
can vary significantly between individual regions of the heart even in the absence of structural alterations39, 
therefore a segmental assessment of strain can be less sensitive in detecting patients with contractile impairment 
than global values.
conclusions
Multilayer evaluation of cardiac contraction is a convenient and fast procedure that can be obtained from basic 
CMR cine images. Measurement of strain and strain rate must be done cautiously as their range varies amply 
within the myocardial volume. Sub-endocardial regions and respectively circumferential strain seems to offer the 
best discriminative tool for the identification of patients with HF.
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